Iovanace Biotherapeutics (IOVA) PT Lowered to $51 at Oppenheimer

May 19, 2021 5:07 AM EDT Send to a Friend

Oppenheimer analyst Mark Breidenbach lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Iovanace Biotherapeutics (IOVA) PT Lowered to $51 at Oppenheimer

Member Login

Free News Feed